Histone deacetylase inhibitor entinostat in combination with a retinoid downregulates HER2 and reduces the tumor initiating cell population in aromatase inhibitor-resistant breast cancer

Amanda J. Schech, Preeti Shah, Stephen Yu, Gauri J. Sabnis, Olga Goloubeva, Paula Rosenblatt, Armina Kazi, Saranya Chumsri, Angela Brodie

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint Dive into the research topics of 'Histone deacetylase inhibitor entinostat in combination with a retinoid downregulates HER2 and reduces the tumor initiating cell population in aromatase inhibitor-resistant breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences